Works by Fishman, Pnina

Results: 30

Drugs Targeting the A3 Adenosine Receptor: Human Clinical Study Data.

Published in:

Molecules, 2022, v. 27, n. 12, p. 3680, doi. 10.3390/molecules27123680

By:

Fishman, Pnina

Publication type:

Article

Namodenoson at the Crossroad of Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular Carcinoma.

Published in:

Biomedicines, 2024, v. 12, n. 4, p. 848, doi. 10.3390/biomedicines12040848

By:

Etzion, Ohad;
Bareket-Samish, Avital;
Yardeni, David;
Fishman, Pnina

Publication type:

Article

Inhibition of IL-17 and IL-23 in Human Keratinocytes by the A3 Adenosine Receptor Agonist Piclidenoson.

Published in:

2018

By:

Cohen, Shira;
Barer, Faina;
Itzhak, Inbal;
Silverman, Michael H.;
Fishman, Pnina

Publication type:

journal article

Targeting the A3 adenosine receptor to treat cytokine release syndrome in cancer immunotherapy.

Published in:

Drug Design, Development & Therapy, 2019, v. 13, p. 491, doi. 10.2147/DDDT.S195294

By:

Cohen, Shira;
Fishman, Pnina

Publication type:

Article

The A3 adenosine receptor agonist, namodenoson, ameliorates non-alcoholic steatohepatitis in mice.

Published in:

International Journal of Molecular Medicine, 2019, v. 44, n. 6, p. 2256, doi. 10.3892/ijmm.2019.4364

By:

Fishman, Pnina;
Cohen, Shira;
Itzhak, Inbal;
Amer, Johnny;
Salhab, Ahmad;
Barer, Faina;
Safadi, Rifaat

Publication type:

Article

Differential effect of adenosine on tumor and normal cell growth: Focus on the A3 adenosine receptor.

Published in:

Journal of Cellular Physiology, 2001, v. 186, n. 1, p. 19, doi. 10.1002/1097-4652(200101)186:1<19::AID-JCP1011>3.0.CO;2-3

By:

Ohana, Gil;
Bar-Yehuda, Sara;
Barer, Faina;
Fishman, Pnina

Publication type:

Article

Adenosine acts as a chemoprotective agent by stimulating G-CSF production: A role for A1 and A3 adenosine receptors.

Published in:

Journal of Cellular Physiology, 2000, v. 183, n. 3, p. 393, doi. 10.1002/(SICI)1097-4652(200006)183:3<393::AID-JCP12>3.0.CO;2-G

By:

Fishman, Pnina;
Bar-Yehuda, Sara;
Farbstein, Tamar;
Barer, Faina;
Ohana, Gil

Publication type:

Article

Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.

Published in:

Oncogene, 2002, v. 21, n. 25, p. 4060, doi. 10.1038/sj.onc.1205531

By:

Fishman, Pnina;
Madi, Lea;
Bar-Yehuda, Sara;
Barer, Faina;
Del Valle, Luis;
Khalili, Kamel

Publication type:

Article

Involvement of Wnt signaling pathway in murine medulloblastoma induced by human neurotropic JC virus.

Published in:

Oncogene, 2001, v. 20, n. 35, p. 4864, doi. 10.1038/sj.onc.1204670

By:

Gan, Dai-Di;
Reiss, Krzysztof;
Carrill, Timothy;
Del Valle, Luis;
Croul, Sidney;
Giordano, Antonio;
Fishman, Pnina;
Khalili, Kamel

Publication type:

Article

A3 Adenosine Receptor Allosteric Modulator Induces an Anti-Inflammatory Effect: In Vivo Studies and Molecular Mechanism of Action.

Published in:

Mediators of Inflammation, 2014, v. 2014, p. 1, doi. 10.1155/2014/708746

By:

Cohen, Shira;
Barer, Faina;
Bar-Yehuda, Sara;
IJzerman, Adriaan P.;
Jacobson, Kenneth A.;
Fishman, Pnina

Publication type:

Article

Autoantibodies to tyrosinase.

Published in:

Cancer (0008543X), 1997, v. 79, n. 8, p. 1461, doi. 10.1002/(SICI)1097-0142(19970415)79:8<1461::AID-CNCR3>3.0.CO;2-E

By:

Fishman, Pnina;
Merimski, Ofer;
Baharav, Ehud;
Shoenfeld, Yehuda

Publication type:

Article

A long‑term complete response to namodenoson in liver cancer with Child‑Pugh B cirrhosis: A case report.

Published in:

2024

By:

Ciurescu, Ioana Adriana;
Lencioni, Riccardo;
Stemmer, Salomon M.;
Farbstein, Motti;
Harpaz, Zivit;
Bareket-Samish, Avital;
Silverman, Michael H.;
Fishman, Pnina

Publication type:

Case Study

Effect of cimetidine on granulocyte-macrophage colony formation by normal and chronic renal failure bone marrow cells.

Published in:

Kidney International, 1984, v. 26, n. 5, p. 741, doi. 10.1038/ki.1984.210

By:

Wienstein, Taly;
Fishman, Pnina;
Klein, Baruch;
Levi, Joseph;
Djaldetti, Meir

Publication type:

Article

Chloramphenicol Induced Inhibition of Platelet Protein Synthesis: in Vitro and in Vivo Studies.

Published in:

British Journal of Haematology, 1976, v. 33, n. 1, p. 53, doi. 10.1111/j.1365-2141.1976.tb00971.x

By:

Agam, Galila;
Gasner, S.;
Bessler, Hana;
Fishman, Pnina;
Djaldetti, M.

Publication type:

Article

The clinical significance of antityrosinase antibodies in melanoma and related hypopigmentary lesions.

Published in:

Clinical Reviews in Allergy & Immunology, 1998, v. 16, n. 3, p. 227, doi. 10.1007/BF02737633

By:

Merimsky, Ofer;
Shoenfeld, Yehuda;
Fishman, Pnina

Publication type:

Article

A3 adenosine receptor allosteric modulator CF602 reverses erectile dysfunction in a diabetic rat model.

Published in:

Andrologia, 2022, v. 54, n. 9, p. 1, doi. 10.1111/and.14498

By:

Itzhak, Inbal;
Cohen, Shira;
Fishman, Sari;
Fishman, Pnina

Publication type:

Article

Suppression of experimental zymosan-induced arthritis by intraperitoneal administration of adenosine.

Published in:

Drug Development Research, 2002, v. 57, n. 4, p. 182, doi. 10.1002/ddr.10148

By:

Baharav, Ehud;
Dubrosin, Anatoly;
Fishman, Pnina;
Bar-Yehuda, Sara;
Halpren, Marisa;
Weinberger, Abraham

Publication type:

Article

Gamma-globulin inhibits tumor spread in mice.

Published in:

International Immunology, 1999, v. 11, n. 8, p. 1247, doi. 10.1093/intimm/11.8.1247

By:

Shoenfeld, Yehuda;
Fishman, Pnina

Publication type:

Article

Platelet X-Ray Microanalysis in Patients with Chronic Renal Failure.

Published in:

Acta Haematologica, 1985, v. 74, n. 4, p. 213, doi. 10.1159/000206221

By:

Djaldetti, Meir;
Fishman, Pnina;
Creter, Draga;
Zahavi, Izhar;
Zevin, Dina;
Levi, Joseph

Publication type:

Article

Scanning and Transmission Electron Microscopy Study on the Plasma Cells of a Patient with Multiple Myeloma.

Published in:

Acta Haematologica, 1977, v. 58, n. 3, p. 173, doi. 10.1159/000207825

By:

Djaldetti, Meir;
Fishman, Pnina

Publication type:

Article

Oral administration of muscle derived small molecules inhibits tumor spread while promoting normal cell growth in mice.

Published in:

Clinical & Experimental Metastasis, 1999, v. 17, n. 6, p. 531, doi. 10.1023/A:1006649617918

By:

Bar-Yehuda, Sara;
Farbstein, Tamar;
Barer, Faina;
Ohana, Gil;
Fishman, Pnina

Publication type:

Article

Editorial: targeting aberrant hepatic inflammation for treatment of non‐alcoholic steatohepatitis—authors' reply.

Published in:

2022

By:

Safadi, Rifaat;
Braun, Marius;
Francis, Adi;
Milgrom, Yael;
Massarwa, Muhammad;
Hakimian, David;
Hazou, Wadi;
Issachar, Assaf;
Harpaz, Zivit;
Farbstein, Motti;
Itzhak, Inbal;
Lev‐Cohain, Naama;
Bareket‐Samish, Avital;
Silverman, Michael H.;
Fishman, Pnina

Publication type:

Editorial

Randomised clinical trial: A phase 2 double‐blind study of namodenoson in non‐alcoholic fatty liver disease and steatohepatitis.

Published in:

Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 11, p. 1405, doi. 10.1111/apt.16664

By:

Safadi, Rifaat;
Braun, Marius;
Francis, Adi;
Milgrom, Yael;
Massarwa, Muhammad;
Hakimian, David;
Hazou, Wadi;
Issachar, Assaf;
Harpaz, Zivit;
Farbstein, Motti;
Itzhak, Inbal;
Lev‐Cohain, Naama;
Bareket‐Samish, Avital;
Silverman, Michael H.;
Fishman, Pnina

Publication type:

Article

CF102 for the Treatment of Hepatocellular Carcinoma: A Phase I/II, Open-Label, Dose-Escalation Study.

Published in:

2013

By:

Stemmer, Salomon M.;
Benjaminov, Ofer;
Medalia, Gal;
Ciuraru, Noab B.;
Silverman, Michael H.;
Bar-Yehuda, Sara;
Fishman, Sari;
Harpaz, Zivit;
Farbstein, Motti;
Cohen, Shira;
Patoka, Renana;
Singer, Barak;
Kerns, William D.;
Fishman, Pnina

Publication type:

Journal Article

CF102 for the Treatment of Hepatocellular Carcinoma: A Phase I/II, Open-Label, Dose-Escalation Study.

Published in:

Oncologist, 2013, v. 18, n. 1, p. 25, doi. 10.1634/theoncologist.2012-0211

By:

Stemmer, Salomon M.;
Benjaminov, Ofer;
Medalia, Gal;
Ciuraru, Noab B.;
Silverman, Michael H.;
Bar‐Yehuda, Sara;
Fishman, Sari;
Harpaz, Zivit;
Farbstein, Motti;
Cohen, Shira;
Patoka, Renana;
Singer, Barak;
Kerns, William D.;
Fishman, Pnina

Publication type:

Article

An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3ß and NF-?B.

Published in:

Oncogene, 2004, v. 23, n. 14, p. 2465, doi. 10.1038/sj.onc.1207355

By:

Fishman, Pnina;
Bar-Yehuda, Sara;
Ohana, Gil;
Barer, Faina;
Ochaion, Avivit;
Erlanger, Abigail;
Madi, Lea

Publication type:

Article

A3 adenosine receptor agonist, CF102, protects against hepatic ischemia/reperfusion injury following partial hepatectomy.

Published in:

Molecular Medicine Reports, 2016, v. 14, n. 5, p. 4335, doi. 10.3892/mmr.2016.5746

By:

OHANA, GIL;
COHEN, SHIRA;
RATH-WOLFSON, LEA;
FISHMAN, PNINA

Publication type:

Article

Ciprofloxacin Affects Pregnancy Loss in CBA/JxDBA/2J Mice Possibly via Elevation of Interleukin-3 and Granulocyte Macrophage-Colony Stimulating Factor Production.

Published in:

American Journal of Reproductive Immunology, 2000, v. 44, n. 5, p. 293, doi. 10.1111/j.8755-8920.2000.440508.x

By:

SAVION, SHOSHANA;
SHEPSHELOVICH, JEANNE;
TODER, VLADIMIR;
BLANK, MIRI;
SHOENFELD, YEHUDA;
FISHMAN, PNINA

Publication type:

Article

The A adenosine receptor (AAR): therapeutic target and predictive biological marker in rheumatoid arthritis.

Published in:

Clinical Rheumatology, 2016, v. 35, n. 9, p. 2359, doi. 10.1007/s10067-016-3202-4

By:

Fishman, Pnina;
Cohen, Shira

Publication type:

Article

Namodenoson Inhibits the Growth of Pancreatic Carcinoma via Deregulation of the Wnt/β-catenin, NF-κB, and RAS Signaling Pathways.

Published in:

Biomolecules (2218-273X), 2023, v. 13, n. 11, p. 1584, doi. 10.3390/biom13111584

By:

Itzhak, Inbal;
Bareket-Samish, Avital;
Fishman, Pnina

Publication type:

Article

Works by Fishman, Pnina

Drugs Targeting the A3 Adenosine Receptor: Human Clinical Study Data.

Namodenoson at the Crossroad of Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular Carcinoma.

Inhibition of IL-17 and IL-23 in Human Keratinocytes by the A<sub>3</sub> Adenosine Receptor Agonist Piclidenoson.

Targeting the A<sub>3</sub> adenosine receptor to treat cytokine release syndrome in cancer immunotherapy.

The A3 adenosine receptor agonist, namodenoson, ameliorates non-alcoholic steatohepatitis in mice.

Differential effect of adenosine on tumor and normal cell growth: Focus on the A3 adenosine receptor.

Adenosine acts as a chemoprotective agent by stimulating G-CSF production: A role for A1 and A3 adenosine receptors.

Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.

Involvement of Wnt signaling pathway in murine medulloblastoma induced by human neurotropic JC virus.

A<sub>3</sub> Adenosine Receptor Allosteric Modulator Induces an Anti-Inflammatory Effect: In Vivo Studies and Molecular Mechanism of Action.

Autoantibodies to tyrosinase.

A long‑term complete response to namodenoson in liver cancer with Child‑Pugh B cirrhosis: A case report.

Effect of cimetidine on granulocyte-macrophage colony formation by normal and chronic renal failure bone marrow cells.

Chloramphenicol Induced Inhibition of Platelet Protein Synthesis: in Vitro and in Vivo Studies.

The clinical significance of antityrosinase antibodies in melanoma and related hypopigmentary lesions.

A3 adenosine receptor allosteric modulator CF602 reverses erectile dysfunction in a diabetic rat model.

Suppression of experimental zymosan-induced arthritis by intraperitoneal administration of adenosine.

Gamma-globulin inhibits tumor spread in mice.

Platelet X-Ray Microanalysis in Patients with Chronic Renal Failure.

Scanning and Transmission Electron Microscopy Study on the Plasma Cells of a Patient with Multiple Myeloma.

Oral administration of muscle derived small molecules inhibits tumor spread while promoting normal cell growth in mice.

Editorial: targeting aberrant hepatic inflammation for treatment of non‐alcoholic steatohepatitis—authors' reply.

Randomised clinical trial: A phase 2 double‐blind study of namodenoson in non‐alcoholic fatty liver disease and steatohepatitis.

CF102 for the Treatment of Hepatocellular Carcinoma: A Phase I/II, Open-Label, Dose-Escalation Study.

CF102 for the Treatment of Hepatocellular Carcinoma: A Phase I/II, Open-Label, Dose-Escalation Study.

An agonist to the A<sub>3</sub> adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3ß and NF-?B.

A<sub>3</sub> adenosine receptor agonist, CF102, protects against hepatic ischemia/reperfusion injury following partial hepatectomy.

Ciprofloxacin Affects Pregnancy Loss in CBA/JxDBA/2J Mice Possibly via Elevation of Interleukin-3 and Granulocyte Macrophage-Colony Stimulating Factor Production.

The A adenosine receptor (AAR): therapeutic target and predictive biological marker in rheumatoid arthritis.

Namodenoson Inhibits the Growth of Pancreatic Carcinoma via Deregulation of the Wnt/β-catenin, NF-κB, and RAS Signaling Pathways.